Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
Therapeutic conversion of the combination of ipratropium and albuterol to tiotropium in patients with chronic obstructive pulmonary disease
Dennis E. Niewoehner
, Robert Lapidus
, Claudia Cote
, Amir Sharafkhaneh
, Mark Plautz
, Philip Johnson
, Steven Kesten
Medicine - Veteran's Administration Medical Center
Research output
:
Contribution to journal
›
Article
›
peer-review
12
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Therapeutic conversion of the combination of ipratropium and albuterol to tiotropium in patients with chronic obstructive pulmonary disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Chronic Obstructive Pulmonary Disease
100%
Albuterol
100%
Tiotropium
100%
Ipratropium
100%
Forced Expiratory Volume in 1 Second (FEV1)
22%
Once-daily
22%
Efficacy Index
22%
Bronchodilation
22%
Other-efficacy
22%
Safety Assessment
11%
Maintenance Therapy
11%
Effectiveness Evaluation
11%
Actuation
11%
Very Severe
11%
Spirometry
11%
Early Morning
11%
Reasonable Expectations
11%
Potential Alternatives
11%
Stable COPD
11%
Daily Maintenance
11%
Safety Reporting
11%
Trough FEV1
11%
Lower Respiratory
11%
Respiratory Adverse Events
11%
Double Dummy
11%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Obstructive Lung Disease
100%
Ipratropium Bromide Plus Salbutamol
100%
Salbutamol
100%
Safety Assessment
16%
Adverse Event
16%